NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Pervasis Therapeutics Inc


Results 1 - 16


Refine Search
Display Mode: Context | Summary
Pervasis Therapeutics Announces $17 Million in Financing and New Board Member
2009 SEP 28 ... Device, Regulatory Actions, Renal Dialysis, Therapy, Treatment, Vascular Disease, Pervasis Therapeutics Inc. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Therapy
Price: $3.00
*
Pervasis Therapeutics Granted Orphan Drug Designation for Vascugel®
2009 MAY 18 ... Actions, Renal Dialysis, Renal Disease, Treatment, U.S. Food and Drug Administration, Pervasis Therapeutics Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Pervasis Therapeutics, Inc.
Price: $3.00
*
SAS® Powers Small, Midsize Biotech and Pharmaceutical Companies
2009 MAR 30 ... Pharmaceuticals Inc., Quark Pharmaceuticals Inc., QuatRx Pharmaceuticals Co., Sapphire Pervasis Therapeutics Inc., Soal Pharmtech Solutions LLC., Sucampo Pharmaceuticals Inc., Therapeutics Inc., and ...
Subject: SAS
Price: $3.00
*
Diagnostics company elects Beverly A. Huss to board of directors
2005 AUG 22 ... directors, effective July 28, 2005. Huss is currently senior advisor to Pervasis Therapeutics, Inc., a Cambridge, Massachusetts-based cell therapy company. ...
Subject: Personnel
Price: $3.00
*
Highland Capital Partners Expands Healthcare Team
2008 NOV 3 ... of Conor Medsystems (IPO; acquired by Johnson & Johnson). He is also the co-founder of Pervasis Therapeutics, a Highland-backed company pioneering regenerative cell-based therapies and ...
Subject: Biotech Business
Price: $3.00
*
Medical device company announces four additions to staff
2005 OCT 24 ... Pervasis Therapeutics, Inc., announced several recent additions to its quickly growing team, ...
Subject: Personnel
Price: $3.00
*
Pervasis Therapeutics announces successful safety results of trials of Vascugel to repair arteries
2006 DEC 11 ... Pervasis Therapeutics, Inc. announced the successful initial safety results of two Phase I ...
Subject: Kidney Disease
Price: $3.00
*
Pervasis Therapeutics Appoints Frank Litvack, M.D., Former CEO of Conor Medsystems, to its Board of Directors
2008 AUG 18 ... Medicine, Medical Device, Regenerative Medicine, Therapy, Tissue Engineering, Treatment, Pervasis Therapeutics Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Pervasis Therapeutics, Inc.
Price: $3.00
*
Pervasis Therapeutics Appoints Life Sciences Industry Executive Frederic Chereau as Company's President and Chief Executive Officer
2008 NOV 3 ... Agreements, Medical Device, Pharmaceutical Business, Pharmaceutical Company, Treatment, Pervasis Therapeutics Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Pervasis Therapeutics, Inc.
Price: $3.00
*
Pervasis Therapeutics Closes Additional $9.75 Million in Financing
2008 JAN 28 ... Medical Device, Nephrology, Renal Dialysis, Renal Disease, Therapy, Treatment, Pervasis Therapeutics Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Clinical Trial Research
Price: $3.00
*
Pervasis Therapeutics Successfully Completes Enrollment for Vascugel Phase II Clinical Trials
2007 AUG 27 ... Biotherapy, Cell Therapy, Clinical Trial Research, Medical Device, Treatment, Pervasis Therapeutics Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Bioengineering
Price: $3.00
*
Pervasis Therapeutics to Present at First Annual Boston Biotech R&D Conference
2008 NOV 3 ... Pervasis Therapeutics, Inc., a pioneer in regenerative cell-based therapies and devices to treat ...
Subject: Pervasis Therapeutics, Inc.
Price: $3.00
*
Pervasis Therapeutics' Vascugel initiates U.S. clinical trials
2006 OCT 23 ... Pervasis Therapeutics, Inc. has been enrolling patients in two Phase I clinical trials of the ...
Subject: Renal Dialysis
Price: $3.00
*
Pervasis Therapeutics, Inc. Named to Red Herring 100, Spring 2007
2007 MAY 28 ... Pervasis Therapeutics, Inc., a pioneer in regenerative cell-based therapies and technologies, ...
Subject: Pervasis Therapeutics, Inc.
Price: $3.00
*
Pervasis Therapeutics, Inc. Selected as a Finalist for the Red Herring 100 North America 2007
2007 APR 30 ... Keywords: Clinical Trial Research, Therapy, Pervasis Therapeutics Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Clinical Trial Research
Price: $3.00
*

Results 1 - 16




-----------------------
PR Login